Overview
Zac Pitts is an Oncologist practicing medicine in Atlanta, Georgia.
Dr. Pitts is highly rated in 1 condition, according to our data. His clinical expertise encompasses Pediatric Low-Grade Glioma (pLGG) and ALK-Positive Non-Small Cell Lung Cancer.
Dr. Pitts is board certified in American Academy Of Nurse Practitioners, 2015. He is actively involved in clinical research, co-authoring 1 peer reviewed article.
Specialties
Licenses
Board Certifications
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- EPO
- HMO
- PPO
- EPO
- HMO
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1365 Clifton Road Northeast, BldgC, Atlanta, GA 30322
Emory Winship Cancer Institute
Suresh Ramalingam is an Oncologist practicing medicine in Atlanta, Georgia. He has been practicing medicine for over 34 years. Dr. Ramalingam is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Small Cell Lung Cancer (SCLC), EGFR Positive Lung Cancer, and Tissue Biopsy. Dr. Ramalingam is board certified in American Board Of Internal Medicine, 2003.
Children's Healthcare Of Atlanta At Hughes Spalding
Carlton Dampier is a Hematologist and an Oncologist practicing medicine in Atlanta, Georgia. Dr. Dampier is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Sickle Cell Disease, Hemoglobinopathy, Congenital Hemolytic Anemia, and Hemolytic Anemia.
Emory Winship Cancer Institute
Mehmet Bilen is an Oncologist practicing medicine in Atlanta, Georgia. He has been practicing medicine for over 18 years. Dr. Bilen is highly rated in 27 conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Prostate Cancer, Urothelial Cancer, Nephrectomy, and Tissue Biopsy. Dr. Bilen is board certified in American Board Of Internal Medicine, 2016.
Frequently Asked Questions about Zac Pitts, NP
How do I make an appointment with Zac Pitts, NP?
You can book an appointment with Zac Pitts, NP by calling their office at 404-778-1900. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Zac Pitts, NP a top-rated expert for Pediatric Low-Grade Glioma (pLGG)?
MediFind is an objective health platform that identifies experts based on real-world data. Zac Pitts, NP is classified as an Advanced expert for Pediatric Low-Grade Glioma (pLGG), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Zac Pitts, NP specialize in?
While Zac Pitts, NP is a Nurse Practitioner, they have specific expertise in Pediatric Low-Grade Glioma (pLGG), ALK-Positive Non-Small Cell Lung Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Nurse Practitioner.
Does Zac Pitts, NP accept my insurance?
Zac Pitts, NP accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 404-778-1900 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Pediatric Low-Grade Glioma (pLGG)
- Experienced
- ALK-Positive Non-Small Cell Lung Cancer